An interleukin-17 inhibitor successfully treated a complicated psoriasis and psoriatic arthritis patient with hepatitis B virus infection and end-stage kidney disease on hemodialysis-Reference-Cited by-同舟云学术

An interleukin-17 inhibitor successfully treated a complicated psoriasis and psoriatic arthritis patient with hepatitis B virus infection and end-stage kidney disease on hemodialysis

Published:2019-02 Issue:2 Volume:5 Page:150-152
ISSN:2352-5126
Container-title:JAAD Case Reports
language:en
Short-container-title:JAAD Case Reports

Author:

Koike Yuta,Fujiki Yumi,Higuchi Maho,Fukuchi Reika,Kuwatsuka Sayaka,Murota Hiroyuki

Publisher

Elsevier BV

Subject

Dermatology

Reference8 articles.

1. Safety of secukinumab in hepatitis B virus;Bevans;J Eur Acad Dermatol Venereol,2018

2. Psoriasis vulgaris in a hepatitis B virus carrier successfully treated with secukinumab and entecavir combination therapy;Yanagihara;Eur J Dermatol,2017

3. British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017;Smith;Br J Dermatol,2017

4. Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy;Oketani;Hepatol Res,2012

5. IL-17A in hepatitis B infection: friend or foe?;Arababadi;Arch Virol,2014

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis B reactivation in PsA patients: an SLR and meta-analysis for IL-17, IL-23 and JAK inhibitors;Rheumatology;2024-08-17

2. Experience of using genetic engineering biological therapy in a patient with psoriasis and chronic renal failure under hemodialysis;Vestnik dermatologii i venerologii;2024-05-20

3. Successful Treatment with Bimekizumab of a Psoriatic Patient Undergoing Hemodialysis: A Case Report and Review of the Literature;Journal of Clinical Medicine;2024-04-12

4. Th17 cells: A new target in kidney disease research;International Reviews of Immunology;2024-03-05

5. Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection;Clinical, Cosmetic and Investigational Dermatology;2023-02